Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-25
SponsorUniversity of Colorado, Denver
About this trial
The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).
Eligibility criteria
Qualifiers
6- 25 years old
Confirmed diagnosis of cystic fibrosis (based on sweat chloride and/or two known disease causing CF mutations)
access to a smart phone and/or internet connection and the ability to complete remote telehealth visits
Disqualifiers
known type 1 or type 2 diabetes, monogenic diabetes
critical illness requiring admission to the ICU
pregnancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
University of Colorado, Denver
Lead sponsor
Cystic Fibrosis Foundation
Collaborator
Baylor College of Medicine
Collaborator
Source ClinicalTrials.gov